Painful Expanding Leg Redness in a Person With Diabetes

Learning objectives#

• Build an anatomic differential for a unilateral red, warm, swollen leg in a person with diabetes.
• Identify purulence, deep-tissue involvement, ischemia, systemic toxicity, and necrotizing features that change urgency and antimicrobial breadth.
• Use ultrasound, radiography, advanced imaging, cultures, and laboratory tests only for questions they can answer.
• Distinguish typical nonpurulent cellulitis from abscess and diabetes-related foot infection requiring source control or multidisciplinary limb care.
• Design antibiotic, edema, portal-of-entry, foot-protection, glycemic, and follow-up plans that prevent both undertreatment and unnecessary broad therapy.

Initial presentation#

Harold, a 62-year-old grocery cashier with type 2 diabetes, calls his clinic because the front of his left lower leg has become red and painful over two days. He noticed a small crack between the fourth and fifth toes after a long shift in damp shoes. The next morning the ankle was warm and swollen. By the following afternoon, redness had extended halfway up the shin and he felt chilled.

He has diabetes complicated by peripheral neuropathy, obesity, chronic venous edema, stage 3 chronic kidney disease, and a remote left ankle fracture. His glycated hemoglobin has been above his individualized goal, partly because he lost coverage for one medicine. He has no prior amputation or known peripheral-artery procedure. He had one episode labeled cellulitis three years earlier. He has never had MRSA documented and does not inject drugs.

At the same-day visit, temperature is 38.0°C, pulse 102 per minute, respiratory rate 20 per minute, blood pressure 128/76 mm Hg, and oxygen saturation normal. He is alert and walks with a limp. The left lower leg has a poorly demarcated, warm, tender erythematous area from the ankle to the mid-shin, with unilateral edema. There is no visible pus, fluctuance, black skin, blistering, crepitus, or rapidly spreading violaceous edge. Pain is significant over the inflamed skin but is not remote from the findings and has not accelerated over hours.

Both shoes and socks are removed. The left fourth toe web contains maceration and a superficial fissure without a deep ulcer. Monofilament sensation is reduced in both feet. Dorsalis pedis pulses are palpable but weaker on the left; capillary refill is slightly delayed yet present. There is no plantar ulcer, probe-to-bone finding, focal bony tenderness, gross deformity, or hot midfoot collapse. Passive ankle movement causes only mild skin discomfort, not severe joint pain.

Harold reports no chest pain, breathlessness, hemoptysis, recent immobilization, surgery, or prior venous thrombosis. He has not measured glucose consistently. He asks for the strongest possible antibiotic because a family member lost a toe after a diabetic infection. The clinician validates the fear while explaining that severity, anatomy, drainage needs, and likely organisms, not the word diabetes alone, determine treatment.

Problem representation#

This is an adult with diabetes, neuropathy, chronic edema, CKD, and a toe-web skin fissure who has an acute unilateral expanding warm tender nonpurulent lower-leg erythema, low-grade fever, and mild tachycardia. The leading diagnosis is nonpurulent cellulitis entering through interdigital skin breakdown. Diabetes, edema, kidney disease, reduced sensation, and uncertain perfusion increase complication risk and lower the threshold for close observation.

The essential competing diagnoses are drainable abscess, venous thrombosis, venous stasis inflammation, acute Charcot arthropathy, gout or septic joint, osteomyelitis, ischemia, and necrotizing soft-tissue infection. The initial examination does not show shock, purulence, deep ulcer, gas, or pain out of proportion, but serious infection requires repeated assessment because early findings can be subtle.

Prioritized differential#

1. Nonpurulent cellulitis#

Acute unilateral warmth, tenderness, diffuse erythema, edema, fever, and a plausible toe-web portal strongly support cellulitis. Streptococci are common in typical nonpurulent disease. Diabetes does not by itself prove gram-negative, anaerobic, or MRSA infection when there is no ulcer, necrosis, water exposure, bite, purulence, or severe immune compromise.

2. Cutaneous or deep abscess#

An abscess requires drainage as the principal source-control treatment. Fluctuance, focal maximal tenderness, spontaneous drainage, a pustule, or ultrasound collection would support it. Harold's inflammation is diffuse, but obesity and edema can hide a deeper collection. Point-of-care ultrasound is selected because the result would change management.

3. Deep-vein thrombosis#

Unilateral swelling, warmth, and pain overlap with DVT. Fever and a skin portal favor cellulitis, while lack of provoking history lowers but does not eliminate thrombosis. Clinical probability is estimated before D-dimer or ultrasound. Cellulitis and DVT can coexist, so a positive infection story should not erase disproportionate venous features.

4. Venous stasis dermatitis or lipodermatosclerosis#

Chronic edema, scaling, hyperpigmentation, and often bilateral inflammation support venous disease. Stasis dermatitis can be warm and uncomfortable but usually evolves differently from acute unilateral fever and rapidly expanding tenderness. Harold's baseline edema may predispose to cellulitis and also complicate visual assessment.

5. Acute Charcot neuro-osteoarthropathy#

Diabetes, neuropathy, warmth, swelling, and sometimes minimal pain make Charcot change important. It usually centers on the foot or ankle rather than diffuse shin skin, can have intact skin, and may show temperature asymmetry and structural change. A normal early radiograph does not exclude it. Continued foot-centered warmth or deformity would trigger offloading and urgent specialist review.

6. Gout, septic arthritis, or inflammatory disease#

Focal joint-centered pain, restricted motion, effusion, crystal history, or aspiration findings would support these diagnoses. Fever and elevated inflammatory markers cannot distinguish gout from infection. Harold's pain is cutaneous and diffuse with relatively preserved joint motion.

7. Osteomyelitis or diabetes-related deep foot infection#

A chronic ulcer, exposed bone, positive probe-to-bone assessment, focal bone pain, deep tract, persistent drainage, or suggestive imaging would raise concern. The superficial toe fissure has no ulcer base or bone exposure. If it deepens or fails to heal, the pathway changes.

8. Necrotizing soft-tissue infection#

Rapid progression, pain beyond visible findings, severe systemic toxicity, bullae, skin anesthesia, crepitus, ecchymosis, gas, hypotension, or organ dysfunction require immediate surgical action. Early disease may lack classic signs. No laboratory score or negative initial image safely overrides strong clinical concern.

9. Acute limb ischemia#

Pain, pallor, pulselessness, paresthesia beyond baseline, paralysis, and a cold limb suggest acute ischemia rather than cellulitis. Diabetes can mask pain, and chronic calcification can complicate ankle-brachial measurements. Harold's foot is warm with present pulses, but perfusion remains part of every reassessment.

Focused history and examination#

The clinician marks symptom timing rather than only the current skin border. Questions cover first lesion, rate of spread, trauma, bite, water or soil exposure, injection, surgery, ulcer, drainage, prior MRSA, antibiotics, recurrent episodes, tinea, edema, venous disease, neuropathy, footwear, and glucose. Severe pain, numbness, bullae, dark skin, confusion, vomiting, and rapid hourly change are necrotizing warnings.

Venous-thrombosis history includes immobilization, surgery, cancer, prior VTE, hormone exposure, long travel, and hemoptysis or breathlessness. Joint and bone questions address focal motion pain, prior gout, hardware, chronic ulcer, and deep drainage. Medication review includes immune-suppressing drugs, glucose therapy, kidney-cleared medicines, and recent antimicrobials.

Examination removes all footwear and dressings and compares both legs. It documents erythema, warmth, tenderness, induration, edema, purulence, fluctuance, lymphangitic streaking, bullae, crepitus, anesthesia, wounds, toe webs, nails, pressure points, and deformity. It assesses joints, compartments, pulses, capillary refill, temperature, motor function, sensation, and gait. A skin marker can help describe spread, but inflammation may extend briefly after therapy and a line does not replace physiology.

Vital signs, mental state, urine output, perfusion, and pain are trended. A patient who becomes less painful because skin sensation is failing is not necessarily improving. Harold's neuropathy makes visual inspection and repeated examination especially important.

Diagnostic strategy#

Decide whether a collection, clot, bone process, or gas is present#

Bedside soft-tissue ultrasound shows cobblestoning compatible with edema but no drainable collection. This supports nonpurulent cellulitis but does not exclude necrotizing infection or osteomyelitis. Venous-ultrasound testing follows a documented probability assessment and shows no proximal DVT. A negative study is interpreted according to the exact protocol and whether symptoms warrant repeat or whole-leg evaluation.

Plain radiographs of the foot and lower leg show soft-tissue swelling without gas, foreign body, acute fracture, or clear bone destruction. Radiography is useful for several alternatives but can be normal early in osteomyelitis and Charcot disease. MRI would be considered if deep infection, osteomyelitis, or Charcot concern persisted after examination and initial imaging. CT or MRI must not delay surgery when necrotizing infection is strongly suspected.

Laboratory studies include blood count, electrolytes, kidney function, glucose, and selected inflammatory or sepsis measures. White-cell count is mildly elevated, creatinine is near baseline, and lactate is normal. These results support current stability but cannot rule out serious infection. Blood cultures are obtained because systemic features and observation are present; they are not necessary for every typical mild cellulitis. Superficial intact-skin swabs are not sent because they do not identify the pathogen in nonpurulent cellulitis.

Classify anatomy before selecting spectrum#

Harold has diffuse nonpurulent lower-leg cellulitis arising near a superficial interdigital fissure, not a chronic infected diabetic foot ulcer with deep polymicrobial features. Empiric treatment therefore targets likely streptococci and selected staphylococcal coverage according to local guidance. MRSA, gram-negative, and anaerobic coverage would be added for defined exposures, purulence, prior microbiology, deep ulcer, necrosis, severe systemic disease, or other risks, not diabetes alone.

Kidney function, allergy, interactions, prior organisms, local resistance, and oral absorption shape the exact agent and dose. A single broad regimen is not specified.

Progressive results and interpretation#

Because Harold has fever, tachycardia, CKD, neuropathy, uncertain home support, and expanding inflammation, he is observed in the hospital and receives initial parenteral therapy under the nonpurulent cellulitis pathway. The toe-web fissure is gently cleaned and protected; maceration and suspected fungal disease receive a separate local plan. The leg is elevated, glucose is monitored, and analgesia avoids preventable kidney harm.

During the first twelve hours, the marked erythema extends one centimeter beyond the line, but pulse, temperature, pain, mental state, and kidney function improve. The team does not declare immediate antibiotic failure from skin appearance alone. Inflammatory changes can lag after effective treatment. They repeat the examination for abscess, necrosis, compartment signs, and ischemia and continue close observation.

By twenty-four hours, fever and tachycardia resolve, tenderness is less intense, and no bullae, anesthesia, purulence, or systemic deterioration appears. The edge stops advancing. Blood cultures remain negative. This trajectory supports uncomplicated nonpurulent cellulitis rather than necrotizing disease or an undrained collection.

Harold transitions to a kidney-appropriate oral agent with a concise total duration and a reassessment plan. Duration may be extended if improvement is slow, but it is not prolonged solely because residual discoloration or edema remains. Pharmacy confirms the medication, and he demonstrates how he will inspect the foot despite reduced sensation.

Podiatry examines footwear and the toe web. Vascular assessment finds no chronic limb-threatening ischemia, while acknowledging that pulse palpation and ankle-brachial measures can be misleading in diabetes. Compression for chronic edema is deferred until acute pain improves and arterial suitability is confirmed, then incorporated into recurrence prevention.

Management plan#

Treat infection at the right breadth#

Typical nonpurulent cellulitis receives therapy active against streptococci, with additional coverage based on the syndrome and local guidance. Purulent infection requires drainage and may require MRSA-active treatment. Deep diabetic-foot infection, necrosis, ischemia, bite, water exposure, or severe immune compromise changes organisms and source-control needs. Broad therapy is narrowed when those features are absent.

Find and control the source#

Abscess drainage, debridement of necrotic tissue, removal of a foreign body, treatment of an infected device, restoration of perfusion, and management of an ulcer are distinct source-control actions. Antibiotics cannot substitute for surgery in necrotizing infection or drainage in an abscess. Harold's portal is a superficial toe-web fissure, so skin care and moisture control accompany antimicrobial treatment.

Protect the limb and the whole patient#

Both feet receive neuropathy, skin, deformity, footwear, and vascular assessment. Offloading is used when a pressure injury or Charcot process is present, not prescribed generically. Glucose is managed without promising that immediate normalization cures infection. Kidney function informs antimicrobial and analgesic choices. Edema elevation and, later, appropriate compression reduce recurrence risk.

Avoid unnecessary procedures and tests#

Routine cultures of intact nonpurulent skin, indiscriminate MRI, and repeated inflammatory markers do not improve every case. Imaging and microbiology are selected when they can reveal a collection, bone infection, gas, foreign body, clot, resistant pathogen, or alternate diagnosis. Clinical response remains the main treatment assessment.

Escalation, referral, and safety net#

Immediate surgical consultation is required for rapidly progressive pain or swelling, pain beyond visible findings, bullae, ecchymosis, skin anesthesia, crepitus, gas, shock, confusion, organ dysfunction, or clinical concern for necrotizing infection. Imaging should not delay exploration when suspicion is high.

Vascular escalation is urgent for a cold pale foot, lost pulses, new motor deficit, rapidly worsening sensory loss, rest pain, gangrene, or an ulcer with ischemia. Podiatry and multidisciplinary diabetic-foot care are urgent for ulceration, deep infection, suspected osteomyelitis, Charcot change, gangrene, or recurrent pressure injury.

After discharge, spreading redness with recurrent fever, new severe pain, blistering, dark skin, pus, faintness, confusion, reduced urine, or rising glucose with illness warrants urgent reassessment. New chest pain, breathlessness, hemoptysis, or marked leg swelling reopens VTE. Harold receives a day-and-night contact and does not rely on sending a photograph to an unattended inbox.

Communication, shared decisions, and equity#

The clinician explains: "The pattern looks most like cellulitis entering through the cracked skin between your toes. We checked for a pocket of pus because that would need drainage, and we assessed a blood clot because swelling can look similar. Diabetes raises the risk of complications, but it does not mean the broadest antibiotic is automatically safest."

Harold's fear of amputation is acknowledged. The team distinguishes current findings from his relative's experience without offering false certainty. He is shown the pulses, skin portal, absence of ulcer or gas, and the features being monitored. The possibility of deterioration is explained through observable signs, not vague reassurance.

Neuropathy, vision, dexterity, work shoes, housing, laundry access, prescription cost, and ability to elevate the leg affect the plan. A mirror and phone camera can help inspection, but photographs do not replace examination when symptoms change. His employer receives functional restrictions with Harold's consent, not diagnostic detail he did not authorize.

Pharmacy chooses an affordable renal-adjusted option and checks interactions. Podiatry identifies a breathable work-shoe strategy and moisture-wicking socks within his budget. Diabetes treatment access is repaired without framing glucose as a moral score. Teach-back covers antibiotic use, foot inspection, toe-web care, edema management, and emergency signs.

Follow-up and contingencies#

Clinical reassessment occurs within a short defined interval to evaluate temperature, pain, spread, edema, wound, perfusion, glucose, kidney function, and adverse effects. Residual redness may take time to resolve; directional improvement in systemic and local findings is more useful than demanding normal skin by a fixed hour.

If the leg fails to improve, the team verifies adherence and absorption, repeats the anatomy, and revisits abscess, resistant organism, DVT, stasis dermatitis, gout, Charcot change, osteomyelitis, ischemia, foreign body, and necrotizing infection. Simply adding antibiotics without revisiting the diagnosis can delay source control.

Longer-term follow-up treats toe-web fungal disease or dermatitis, chronic edema, venous insufficiency, neuropathy, footwear pressure, and diabetes access. Recurrent episodes are counted and verified because misdiagnosed stasis inflammation should not lead to indefinite prophylactic antibiotics. Selected patients with frequent proven recurrence despite risk-factor control may discuss prophylaxis under specialist guidance.

If a future ulcer develops, the case enters a diabetes-related foot-infection pathway with depth, perfusion, bone, cultures, offloading, and multidisciplinary assessment. If the foot becomes hot and swollen with intact skin and little pain, Charcot arthropathy is reconsidered urgently even without deformity.

Reasoning traps and alternative pathways#

• Calling every red diabetic leg cellulitis: Venous disease, DVT, gout, Charcot change, ischemia, trauma, and contact dermatitis are common mimics.
• Calling every diabetic-leg infection polymicrobial: Anatomy, ulceration, necrosis, exposure, depth, and severity determine likely organisms.
• Treating an abscess with antibiotics alone: Drainage is the primary source control for a collection.
• Using a superficial swab for nonpurulent cellulitis: It samples colonizers rather than the infected dermis.
• Using a normal white-cell count or lactate as a rule-out: Early or immune-modified serious infection can have reassuring laboratories.
• Using LRINEC to exclude necrotizing disease: Laboratory scores lack sufficient sensitivity for that purpose.
• Waiting for CT or MRI before calling surgery: Strong clinical concern for necrotizing infection requires immediate surgical evaluation.
• Escalating antibiotics because redness crosses a line in the first hours: Reassess the whole trajectory and anatomy; skin inflammation can lag.
• Ignoring perfusion because pulses are palpable: Diabetes and calcification complicate vascular assessment, and ischemia changes healing and source control.
• Stopping after the infection clears: Toe-web disease, edema, neuropathy, footwear, and access drive recurrence.

An alternative patient with a fluctuant collection would undergo drainage and culture of pus. A deep plantar ulcer with bone exposure would require diabetic-foot and osteomyelitis evaluation. A hot swollen neuropathic midfoot with intact skin could be acute Charcot disease and needs offloading. Abrupt ischemic signs require vascular emergency care. Pain out of proportion, bullae, shock, or tissue gas would prompt immediate surgery and broad resuscitative antimicrobial coverage.

Evidence limits and what could change#

Cellulitis has no single confirmatory test, and diagnostic misclassification is common. Trials often enroll uncomplicated cases and exclude severe diabetes-related foot disease, immune compromise, ischemia, or systemic toxicity. Antibiotic findings should not be extrapolated beyond the studied anatomy and severity.

The IDSA skin-infection guideline predates some newer trials, while the 2023 IWGDF and IDSA guideline specifically addresses diabetes-related foot infections. A lower-leg cellulitis without an ulcer is not identical to a diabetic-foot infection. Local resistance, emerging pathogens, and new oral agents may change choices, but source control and syndrome classification remain primary.

Necrotizing-infection scores and imaging have imperfect sensitivity. Surgical exploration remains the definitive assessment when clinical concern is high. Conversely, indiscriminate emergency surgery or broad antibiotics for every red leg causes harm. Repeated examination and trajectory are essential.

Foot-risk and vascular tests can be affected by neuropathy, edema, calcified arteries, technique, and access. Future imaging or biomarkers may improve discrimination. Until then, the durable method is to expose and examine both feet, define depth and purulence, assess perfusion and systemic illness, treat the likely syndrome, and reopen the differential when recovery deviates.

Key points#

• A unilateral red swollen leg in diabetes requires an anatomic differential, not an automatic infection label.
• Typical nonpurulent cellulitis, abscess, deep diabetic-foot infection, and necrotizing disease require different organisms and source-control plans.
• Ultrasound can find a collection or DVT but cannot exclude every deep or necrotizing process.
• No laboratory score safely rules out necrotizing infection when clinical concern is high.
• Antibiotic breadth should follow purulence, depth, exposure, prior microbiology, systemic severity, perfusion, and local resistance—not diabetes alone.
• Recurrence prevention treats portals of entry, edema, neuropathy, footwear, vascular health, and diabetes access after the acute episode resolves.